NWS
77
8
KO
52
5
SO
70
-3
CME
33
-4
PVH
63
5
GWW
46
2
GS
65
2
TGNA
58
4
VLO
33
-5
VMC
57
3
OKE
62
-2
NVDA
60
-5
EW
40
2
ICE
67
3
SNA
53
-3
NWL
32
4
DE
29
-3
FCX
47
-9
OMC
53
3
CFG
34
4
NWS
77
8
KO
52
5
SO
70
-3
CME
33
-4
PVH
63
5
GWW
46
2
GS
65
2
TGNA
58
4
VLO
33
-5
VMC
57
3
OKE
62
-2
NVDA
60
-5
EW
40
2
ICE
67
3
SNA
53
-3
NWL
32
4
DE
29
-3
FCX
47
-9
OMC
53
3
CFG
34
4
Financhill
Back

ProPhase Labs Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
29

PRPH
ProPhase Labs

Last Price:
4.36
Seasonality Move:
6.86%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
29
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $4.39. The Score for PRPH is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $4.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 36.87 Sell
Chaikin Money Flow: -14685 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.58 - 5.14) Sell
Bollinger Bands (100): (4.61 - 5.89) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.55 Sell
20-day SMA: 4.79 Sell
50-day SMA: 5.12 Sell
200-day SMA: 4.93 Sell
8-day EMA: 4.53 Sell
20-day EMA: 4.73 Sell
50-day EMA: 5.01 Sell
200-day EMA: 5.43 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.18 per share, and an increase next year of $1.40 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):